US2544272A - Penicillin salt suspensions - Google Patents
Penicillin salt suspensions Download PDFInfo
- Publication number
- US2544272A US2544272A US1277A US127748A US2544272A US 2544272 A US2544272 A US 2544272A US 1277 A US1277 A US 1277A US 127748 A US127748 A US 127748A US 2544272 A US2544272 A US 2544272A
- Authority
- US
- United States
- Prior art keywords
- penicillin
- oil
- salt
- percent
- insoluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002960 penicillins Chemical class 0.000 title description 21
- 239000000725 suspension Substances 0.000 title description 11
- 239000000203 mixture Substances 0.000 claims description 37
- 239000003995 emulsifying agent Substances 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 15
- 230000001225 therapeutic effect Effects 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 150000008064 anhydrides Chemical class 0.000 claims description 4
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical class N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 17
- 229930182555 Penicillin Natural products 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 229940049954 penicillin Drugs 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 14
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 13
- 239000003981 vehicle Substances 0.000 description 10
- -1 hexitol anhydrides Chemical class 0.000 description 7
- 239000012053 oil suspension Substances 0.000 description 7
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical class FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 6
- 239000008159 sesame oil Substances 0.000 description 6
- 235000011803 sesame oil Nutrition 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000001593 sorbitan monooleate Substances 0.000 description 5
- 235000011069 sorbitan monooleate Nutrition 0.000 description 5
- 229940035049 sorbitan monooleate Drugs 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 229920001281 polyalkylene Polymers 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical class [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000008041 oiling agent Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010491 poppyseed oil Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical class CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
Definitions
- This invention relates to penicillin salts and more particularly to improvements in oil suspensions of insoluble salts of penicillin.
- the water-insoluble organic salts of penicillin which are capable of this unexpected prolongation are administered as suspensions in aqueous or oleaginous vehicles.
- aqueous suspensions When aqueous suspensions are used, the suspension must be freshly prepared because of the well known instability of penicillin in the presence of moisture.
- no substantial amount of moisture is present in the preparation and in such mixtures the penicillin salts are stable over a long period of time. According y. it is most convenient to supply oil suspensions to the trade, and to furnish the preparations in bottles containing the insoluble penicillin salt in finely divided form already mixed with the oil vehicle.
- the insoluble salt of penicillin which of course is finely divided to permit its free passage through the lumen of the hypodermic needle, does not remain in suspension, however, and before parenteral administration it is necessary for the technician or physician to resuspend the salt by agitating the preparation, as by shaking. It has been found that after standing for a period of a few days the finely divided salt which separates from the oil vehicle forms a stable mass of solid material which is resuspendable only by prolonged and violent agitation of the bottle containing the penicillin-oil mixture. The reason for the formation of this stable layer of solid material is not understood.
- Mixtures of insoluble organic penicillin salts and oleaginous vehicles prepared in accordance with this invention may be mixed by mere gentle shaking, to produce uniform and complete suspensions of the insoluble penicillin salts in the vehicles, even after the mixtures have stood for long periods of time.
- compositions In the provision of novel compositions according to my invention, care must be exercised in the selection of the emulsifying agents used to prevent the formation of the undesirable stable layer of insoluble penicillin salt, and especially so since the compositions are to be administered parenterally as medicaments.
- the agents chosen must be nontoxic, must be oil-soluble, must be substantially free from irritating properties, must not impart undesirable odor or color to the medicament and must have no untoward action upon the oil vehicle or the insoluble penicillin salt.
- compositions comprising a group consisting of the fatty acid partial esters of hexitol anhydrides, including such anhydrides as sorbitans, sorbides, mannitans and mannides, and the polyalkylene derivatives of the above anhydrides.
- Preferred compounds of the above described types of agents are those which contain fatty acid residues having from about 12 to about 18 carbon atoms, for example the residues of oleic, lauric and stearic acids.
- the preferred polyalkylene derivatives mentioned above are those prepared by reacting ethylene oxide or propylene oxide with the partial fatty acid esters of hexitol anhydrides, with the amount of ethylene oxide or propylene oxide introduced in the molecule not exceeding a ratio of about 25 molecules of oxide to one of the anhydride.
- the amounts of the above emulsifying agents employed in compositions prepared in accordance with my invention are much less than the range of 2 to 5 percent commonly employed in preparing oil-water emulsions.
- concentrations of 2 or more percent by volume are effective, efiicient results are obtained when the concentration of emulsifying agent employed in the penicillin salt-oil mixture does not exceed one percent, and surprisingly the effectiveness of the emulsifying agent in producing an easily redispersible penicillin salt mixture attains its optimal value when the concentration is about 0.125 percent. It is difficult to account for this surprising optimal concentration and I I know of no suitable explanation of this phenomenon.
- compositions prepared in accordance with my invention contain emulsifying agents in effective amounts up to about 1 percent, and most desirably they contain a concentration of about 0.125 percent by volume.
- procaine penicillin oil suspension prepared in accordance with the above procedure and a sample of procaine penicillin in sesame oil which contained no emulsifying agent were centrifuged at 2500 R. P. M. for about 40 minutes to cause complete separation of the suspended procaine penicillin salt.
- the procaine penicillin salt in the mixture of oil and emulsifying agent was readily resuspendable upon gentle shaking for a few seconds, whereas the procaine penicillin salt in the plain oil vehicle was resuspendable only upon violent and prolonged'shaklng for manyminutes.
- Example 2 The procedure of Example 1 may be followed in preparing a composition comprising the following ingredients and proportions thereof:
- the above composition has a total volume of about 1500 ml. and contains about 0.25 percent of emulsifying agent.
- Example 3 The following composition containing about 1 percent of emulsifying agent may be prepared according to the procedure of Example 1:
- Example 4 The following composition containing about 0.08 percent of emulsifying agent may be prepared according to the procedure of Example 1:
- oleaginous media comprising oils and liquid oil-wax mixtures which may be referred to as physiologically compatible oils, and with which my invention is operative, include both parenterally and topically useful oils.
- Oils suitable for parenteral administration include the non-drying vegetable oils, such as rapeseed, cottonseed, poppy seed oil and the like, as well as the lower aliphatic esters of the fatty acids, for example ethyl oleate and ethyl stearate.
- An illustrative example of an oil suitable for topical application is liquid petrolatum.
- physiologicallycompatible waxes are beeswax and spermaceti.
- compositions containing the insoluble penicillin salt in finely divided form are desirable. This fine division is especially desirable in compositions intended for injection purposes to avoid the tendency of the particles of the penicillin salt mechanically to pack" in the lumen of the hypodermic needle.
- penicillin salt-oil suspensions in which the penicillin has been ground or powdered until it will pass through a ZOO-mesh screen.
- the size of the penicillin salt particles is not critical for the purposes of my invention, and my invention is operative with penicillin salt particles even of such size as will pass through a 40-mesh or coarser screen.
- a readily redispersible substantially waterfree therapeutic composition comprising a major proportion of an oleaginous vehicle, a minor proportion of a finely divided water-insoluble, and
- oil-insoluble organic penicillin salt and an amount eifective to cause redispersion and less than about one percent by volume of at least one emulsifying agent of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivativesI 2.
- An injectable readily redispersible therapeutic composition being substantially water-free, comprising a non-drying vegetable oil, a finely divided water-insoluble, and oil-insoluble organic penicillin saltand in total amount about 0.125 percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyakylene oxide derivatives.
- a readily redispersible substantially waterfree therapeutic composition comprising a nondrying vegetable oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides "and their polyalkylene oxide derivatives.
- a readily redispersible substantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of thegroup consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivatives.
- a readily redispersiblesubstantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause 'redispersion and less than about one percent by volume of a mixture of sorbitan mono-'oleate and the polyethylene oxide derivative of sorbitan mono-oleate.
- composition according to claim 5 in which the mixture of sorbitan mono-oleate and the poly-' ethylene oxide derivative of sorbitan mono-oleate is present in a concentration of about one eighth of one percent by volume.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Patented Mar. 6, 1951 PENICIILIN SALT SUSPENSIONS Henry C. Miller, Indianapolis, Ind., assignor to Eli Lilly and Company, Indianapolis, Ind., a corporation oflndiana No Drawing. Application January 8, 1948, Serial No. 1,277
6 Claims. (Cl. 167- 58) I This invention relates to penicillin salts and more particularly to improvements in oil suspensions of insoluble salts of penicillin.
It has recently been discovered that certain" organic salts of penicillin having a substantial insolubility in water and oil are valuable in the treatment of infections for which penicillin itself is commonly used. and that these insoluble organic salts possess an advantage over aqueous solutions of the water-soluble metal salts of penicillin in that the duration of action of the penicillin is greatly enhanced. Thus, for example, only one or two parenteral administrations of the insoluble organic penicillin salts are required per diem in place of the six or more injections required when solutions of water-soluble penicillin salts are being administered.
The water-insoluble organic salts of penicillin which are capable of this unexpected prolongation are administered as suspensions in aqueous or oleaginous vehicles. When aqueous suspensions are used, the suspension must be freshly prepared because of the well known instability of penicillin in the presence of moisture. However, in the case of oil suspensions, the subject with which my invention is concerned, no substantial amount of moisture is present in the preparation and in such mixtures the penicillin salts are stable over a long period of time. According y. it is most convenient to supply oil suspensions to the trade, and to furnish the preparations in bottles containing the insoluble penicillin salt in finely divided form already mixed with the oil vehicle. The insoluble salt of penicillin, which of course is finely divided to permit its free passage through the lumen of the hypodermic needle, does not remain in suspension, however, and before parenteral administration it is necessary for the technician or physician to resuspend the salt by agitating the preparation, as by shaking. It has been found that after standing for a period of a few days the finely divided salt which separates from the oil vehicle forms a stable mass of solid material which is resuspendable only by prolonged and violent agitation of the bottle containing the penicillin-oil mixture. The reason for the formation of this stable layer of solid material is not understood.
but whatever its cause, it makes diflicult the reform suspensions of the salts. Other objects will become apparent from the following description.
In the accomplishment of the above and other objects I have discovered that readily resuspendable mixtures of finely divided insoluble organic salts of penicillin in oleaginous vehicles are obtained when there is added to the oleaginous mixture a small amount of one or more agents commonly classified as emulsifying agents. The small amount of emulsifying agent which is added is not sufllcient to produce a stable suspension or even to cause any observable inhibition of the separation of the penicillin salt from the oil vehicle, but surprisingly, for some reason unknown to me, the small amount of agent does prevent the separated salt from forming the solid mass of salt which resists resuspension. Mixtures of insoluble organic penicillin salts and oleaginous vehicles prepared in accordance with this invention, unlike those which have hitherto been used, may be mixed by mere gentle shaking, to produce uniform and complete suspensions of the insoluble penicillin salts in the vehicles, even after the mixtures have stood for long periods of time.
In the provision of novel compositions according to my invention, care must be exercised in the selection of the emulsifying agents used to prevent the formation of the undesirable stable layer of insoluble penicillin salt, and especially so since the compositions are to be administered parenterally as medicaments. The agents chosen must be nontoxic, must be oil-soluble, must be substantially free from irritating properties, must not impart undesirable odor or color to the medicament and must have no untoward action upon the oil vehicle or the insoluble penicillin salt. I have found that emulsifying agents fully meeting the above medical and other requirements are compositions comprising a group consisting of the fatty acid partial esters of hexitol anhydrides, including such anhydrides as sorbitans, sorbides, mannitans and mannides, and the polyalkylene derivatives of the above anhydrides. Preferred compounds of the above described types of agents are those which contain fatty acid residues having from about 12 to about 18 carbon atoms, for example the residues of oleic, lauric and stearic acids. The preferred polyalkylene derivatives mentioned above are those prepared by reacting ethylene oxide or propylene oxide with the partial fatty acid esters of hexitol anhydrides, with the amount of ethylene oxide or propylene oxide introduced in the molecule not exceeding a ratio of about 25 molecules of oxide to one of the anhydride.
The amounts of the above emulsifying agents employed in compositions prepared in accordance with my invention are much less than the range of 2 to 5 percent commonly employed in preparing oil-water emulsions. In my invention, although concentrations of 2 or more percent by volume are effective, efiicient results are obtained when the concentration of emulsifying agent employed in the penicillin salt-oil mixture does not exceed one percent, and surprisingly the effectiveness of the emulsifying agent in producing an easily redispersible penicillin salt mixture attains its optimal value when the concentration is about 0.125 percent. It is difficult to account for this surprising optimal concentration and I I know of no suitable explanation of this phenomenon. I have found that a mixture of emulsifying agents of the above types may be employed and that the most effective results are obtained when the total concentration of the mixure of emulsifying agents is about 0.125 percent. Thus, preferred compositions prepared in accordance with my invention contain emulsifying agents in effective amounts up to about 1 percent, and most desirably they contain a concentration of about 0.125 percent by volume.
Illustrations of novel compositions and their preparation in accordance with my invention are set forth in the following specific examples.
Example .1
24 liters of sesame oil, 24 cc. of the polyethylene oxide derivative of sorbitan mono-oleate and 13.5 cc. of sorbitan mono-oleate are mixed with stirring and the mixture is sterilized by heating it to about 150 C. for 3 hours. The mixture is cooled to about 45 C., and under sterile conditions and with vigorous stirring 9 kg. (9 billion units) of the procaine salt of penicillin in finely divided condition (200 mesh screen) are added. The above composition has a total volume of about 30 liters and on a percentage basis contains about 0.125 percent of emulsifying agent. The sterile suspension thus obtained is then placed in small sterile bottles suitable for distribution to the trade, and sealed. During the filling of the bottles with the sterile suspension of procaine penicillin in oil, it is of course necessary to maintain an even distribution of the penicillin salt in the oil by agitation of the mixture.
A sample of the oil suspension of procaine penicillin prepared in accordance with the above procedure was allowed to stand for two weeks. At the end of the two weeks period the mixture was found to be readily resuspendable by gentle shaking for a few seconds. In comparison, a sample of procaine penicillin suspended in sesame oil without the addition of the emulsifying agent, and which was allowed to stand for two weeks, was found to be resuspendable only upon violent shaking of the sample for a period of about minutes.
A sample of procaine penicillin oil suspension prepared in accordance with the above procedure and a sample of procaine penicillin in sesame oil which contained no emulsifying agent were centrifuged at 2500 R. P. M. for about 40 minutes to cause complete separation of the suspended procaine penicillin salt. The procaine penicillin salt in the mixture of oil and emulsifying agent was readily resuspendable upon gentle shaking for a few seconds, whereas the procaine penicillin salt in the plain oil vehicle was resuspendable only upon violent and prolonged'shaklng for manyminutes.
Example 2 The procedure of Example 1 may be followed in preparing a composition comprising the following ingredients and proportions thereof:
Cottonseed oil ml 1200 Procaine penicillin g 450 sorbitan mono-oleate ml 3.7
The above composition has a total volume of about 1500 ml. and contains about 0.25 percent of emulsifying agent.
Example 3 The following composition containing about 1 percent of emulsifying agent may be prepared according to the procedure of Example 1:
Peanut oil ml 1000 Profiavin penicillin g 250 Polyoxyalkylene derivative of sorbitan monopalmitate ml 9.2.5
Example 4 The following composition containing about 0.08 percent of emulsifying agent may be prepared according to the procedure of Example 1:
Sesame oil ml 2400 Procaine penicillin g 500 Gentian violet salt of penicillin g 400 Sorbitan mono-oleate ml 2.4
dients may be employed.
As is known to the art, a wide variety of oleaginous media may be employed in the preparation of penicillin salt suspensions suitable for therapeutic purposes. Suitable oleaginous dispersion media comprising oils and liquid oil-wax mixtures which may be referred to as physiologically compatible oils, and with which my invention is operative, include both parenterally and topically useful oils. Oils suitable for parenteral administration include the non-drying vegetable oils, such as rapeseed, cottonseed, poppy seed oil and the like, as well as the lower aliphatic esters of the fatty acids, for example ethyl oleate and ethyl stearate. An illustrative example of an oil suitable for topical application is liquid petrolatum. Examples of physiologicallycompatible waxes are beeswax and spermaceti.
As is known, for therapeutic purposes, compositions containing the insoluble penicillin salt in finely divided form are desirable. This fine division is especially desirable in compositions intended for injection purposes to avoid the tendency of the particles of the penicillin salt mechanically to pack" in the lumen of the hypodermic needle. Thus it is the practice to provide penicillin salt-oil suspensions in which the penicillin has been ground or powdered until it will pass through a ZOO-mesh screen. However, the size of the penicillin salt particles is not critical for the purposes of my invention, and my invention is operative with penicillin salt particles even of such size as will pass through a 40-mesh or coarser screen. In general, it may be said that the more finely divided the penicillin salt, the more tenaciously the particles of salt adhere to each other and the more difiicultly the solid mass which settles out is redispersible. Hence, my invention is of greater importance in connection with penicillin salt-oil suspensions in which the penicillin salt is in a finely divided state, a condition which is presently preferred for therapeutic compositions.
I claim:
1. A readily redispersible substantially waterfree therapeutic composition comprising a major proportion of an oleaginous vehicle, a minor proportion of a finely divided water-insoluble, and
oil-insoluble organic penicillin salt and an amount eifective to cause redispersion and less than about one percent by volume of at least one emulsifying agent of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivativesI 2. An injectable readily redispersible therapeutic composition being substantially water-free, comprising a non-drying vegetable oil, a finely divided water-insoluble, and oil-insoluble organic penicillin saltand in total amount about 0.125 percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides and their polyakylene oxide derivatives.
3. A readily redispersible substantially waterfree therapeutic composition comprising a nondrying vegetable oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of the group consisting of the fatty acid partial esters of hexitol anhydrides "and their polyalkylene oxide derivatives.
4. A readily redispersible substantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause redispersion and less than about one percent by volume of at least one member of thegroup consisting of the fatty acid partial esters of hexitol anhydrides and their polyalkylene oxide derivatives.
5. A readily redispersiblesubstantially waterfree therapeutic composition comprising sesame oil, finely divided procaine penicillin and an amount effective to cause 'redispersion and less than about one percent by volume of a mixture of sorbitan mono-'oleate and the polyethylene oxide derivative of sorbitan mono-oleate.
6. A composition according to claim 5 in which the mixture of sorbitan mono-oleate and the poly-' ethylene oxide derivative of sorbitan mono-oleate is present in a concentration of about one eighth of one percent by volume.
HENRYC. MILLER.
REFERENCES CITED The following references are of record in the file of this patent:
OTHER REFERENCES
Claims (1)
1. A READILY REDISPERSIBLE SUBSTANTIALLY WATERFREE THERAPEUTIC COMPOSITION COMPRISING A MAJOR PROPORTION OF AN OLEAGINOUS VEHICLE, A MINOR PROPORTION OF A FINELY DIVIDED WATER-INSOLUBLE, AND OIL-INSOLUBLE ORGANIC PENICILIN SALT AND AN AMOUNT EFFECTIVE TO CAUSE REDISPERSION AND LESS THAN ABOUT ONE PERCENT BY VOLUME OF AT LEAST ONE EMULSIFYING AGENT OF THE GROUP CONSISTING OF THE FATTY ACID PARTIAL ESTERS OF HEXITIL ANHYDRIDES AND THEIR POLYALKYLENE OXIDE DERIVATIVES.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1277A US2544272A (en) | 1948-01-08 | 1948-01-08 | Penicillin salt suspensions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1277A US2544272A (en) | 1948-01-08 | 1948-01-08 | Penicillin salt suspensions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2544272A true US2544272A (en) | 1951-03-06 |
Family
ID=21695221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US1277A Expired - Lifetime US2544272A (en) | 1948-01-08 | 1948-01-08 | Penicillin salt suspensions |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2544272A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2698822A (en) * | 1951-04-28 | 1955-01-04 | Fougera & Co Inc E | Cardiac glycoside buccal composition |
| US2725336A (en) * | 1950-11-06 | 1955-11-29 | Pfizer & Co C | Preparation containing modified procaine penicillin crystals and process for preparing such crystals |
| US2812283A (en) * | 1950-11-29 | 1957-11-05 | Geschickter Fund Med Res | Therapeutic solvent vehicle |
| US2875130A (en) * | 1956-11-20 | 1959-02-24 | Smith Kline French Lab | Method of preparing sustained release particles and the product of the method |
| US2928769A (en) * | 1957-07-22 | 1960-03-15 | Strong Cobb And Company Inc | Production of controlled release medicaments |
| US3049473A (en) * | 1956-08-13 | 1962-08-14 | Ici Ltd | Udder-dispersible antibiotic mastitis creams |
| US3194733A (en) * | 1961-04-26 | 1965-07-13 | Olin Mathicson Chemical Corp | Phenothiazine compositions and method of treating mental disorders |
-
1948
- 1948-01-08 US US1277A patent/US2544272A/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| None * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2725336A (en) * | 1950-11-06 | 1955-11-29 | Pfizer & Co C | Preparation containing modified procaine penicillin crystals and process for preparing such crystals |
| US2812283A (en) * | 1950-11-29 | 1957-11-05 | Geschickter Fund Med Res | Therapeutic solvent vehicle |
| US2698822A (en) * | 1951-04-28 | 1955-01-04 | Fougera & Co Inc E | Cardiac glycoside buccal composition |
| US3049473A (en) * | 1956-08-13 | 1962-08-14 | Ici Ltd | Udder-dispersible antibiotic mastitis creams |
| US2875130A (en) * | 1956-11-20 | 1959-02-24 | Smith Kline French Lab | Method of preparing sustained release particles and the product of the method |
| US2928769A (en) * | 1957-07-22 | 1960-03-15 | Strong Cobb And Company Inc | Production of controlled release medicaments |
| US3194733A (en) * | 1961-04-26 | 1965-07-13 | Olin Mathicson Chemical Corp | Phenothiazine compositions and method of treating mental disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2507193A (en) | Penicillin product | |
| DE3856297T2 (en) | Amorphous form of aztreonam | |
| JPH06507913A (en) | Novel compositions based on derivatives of taxanes | |
| CA2222081A1 (en) | Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents | |
| US2544272A (en) | Penicillin salt suspensions | |
| DE2635476C2 (en) | Veterinary medicinal products | |
| CZ297632B6 (en) | Improved pharmaceutical compositions | |
| JPS647046B2 (en) | ||
| JPH0558410B2 (en) | ||
| US2768112A (en) | Repository vitamin compositions | |
| DE2611183A1 (en) | STABLE DOSAGE FORM OF PROSTAGLANDIN-LIKE COMPOUNDS | |
| DE2310770A1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING PENICILLIN COMPOUNDS | |
| US2518510A (en) | Stable injectable oil-pectin therapeutic compositions | |
| CA1160571A (en) | Antitumor compositions | |
| US2966442A (en) | Antibiotic compositions | |
| US2600344A (en) | Androgenic composition | |
| IE42951B1 (en) | Injectable antibiotic compositions | |
| CH673395A5 (en) | ||
| EP0353267A1 (en) | Emulsion for parenteral administration. | |
| US2725336A (en) | Preparation containing modified procaine penicillin crystals and process for preparing such crystals | |
| JPH05186348A (en) | Preparation of aqueous suspension agent | |
| US2650217A (en) | Production of quinine-penicillin | |
| US2719103A (en) | D-tubo-curarine chloride in suspension of water-insoluble soap in injectable oil | |
| US2690414A (en) | Repository pollen extract compositions | |
| US2694665A (en) | Procaine-penicillin g composition |